Tag: Disaster Planning

Study: SARS-CoV-2 particles may travel farther than once thought

Editor's Note This study by researchers at the US Department of Energy’s Pacific Northwest National Laboratory, Richland, Washington, finds that small respiratory particles can remain moist and airborne for a longer time and greater distance than scientists have recognized. The researchers found that mucus shells surrounding respiratory droplets--emitted from the…

Read More

By: Judy Mathias
February 16, 2022
Share

Patients rate telehealth physician visits favorably during COVID-19 pandemic

Editor's Note This study by UCLA researchers finds patient experiences with telehealth physician appointments during the COVID-19 pandemic were as positive as traditional face-to-face visits and phone visits, or even more so. The researchers surveyed 58,509 adult patients on their 13,928 primary care and 44,581 specialty physician visits at 197…

Read More

By: Judy Mathias
February 16, 2022
Share

Likelihood of acute COVID-19 in RT-PCR negative patients

Editor's Note This study by researchers at Rutgers New Jersey Medical School finds that treatment for COVID-19 should be based on clinical judgment and not just testing. Between April and October 2020, the researchers looked at four groups: 40 patients who were RT-PCR confirmed positive 20 patients who repeatedly tested…

Read More

By: Judy Mathias
February 14, 2022
Share

The Joint Commission begins surveying for COVID-19 vaccinations in 24 states

Editor's Note As of February 14, The Joint Commission began surveying to the COVID-19 vaccination requirements in the 24 states that were not previously subject to the Centers for Medicare and Medicaid Services (CMS) “Omnibus COVID-19 Health Care Staff Vaccination” interim final rule. Healthcare organizations in these 24 states must…

Read More

By: Judy Mathias
February 14, 2022
Share

Vaccination rates and new COVID-19 infections by US county

Editor's Note This study led by researchers at the University of Cincinnati, finds that areas with low vaccination rates experienced a more intense surge of new cases during the third wave of the COVID-19 pandemic, primarily driven by the Delta variant. In the analysis, COVID-19 infections per 100,000 people during…

Read More

By: Judy Mathias
February 10, 2022
Share

Healthcare professionals can help combat vaccination hesitancy

  Editor's Note A Centers for Disease Control and Prevention (CDC) national survey analysis found that a recommendation from a healthcare provider may help increase COVID-19 vaccination rates, according to a February 8 report in JAMA. The survey, analyzed in the December 17, 2021, Morbidity and Mortality Weekly Report, titled…

Read More

By: Tarsilla Moura
February 10, 2022
Share

New inhaled vaccine delivers broad protection against COVID-19, variants

Editor's Note In this study, Canadian researchers at McMaster University (Hamilton, Ontario) confirm that their newly developed inhaled form of COVID-19 vaccine provides long-lasting protection against the original strain of SARS-Cov-2 and variants of concern. The researchers compared two types of adenovirus platforms for the vaccine. The adenoviruses serve as…

Read More

By: Judy Mathias
February 10, 2022
Share

HHS to give $66.5 million towards community-based outreach to boost COVID-19 vaccination rates

Editor's Note According to the February 10 Healthcare Purchasing News, the US Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a new American Rescue Plan funding of $66.5 million to help expand outreach efforts to boost COVID-19 vaccine rates. The funding will…

Read More

By: Tarsilla Moura
February 10, 2022
Share

Vaccine effectiveness against COVID-19 during 9 months after second vaccination

Editor's Note This study by researchers at Umea University in Sweden finds a progressive waning in vaccine effectiveness against COVID-19 of any severity during the first 9 months after the second vaccination, with the rate of waning differing by vaccine type Analyzing the total population of Sweden, vaccine effectiveness was…

Read More

By: Judy Mathias
February 8, 2022
Share

FDA: Class I recall of Empowered Diagnostics COVID-19 tests

Editor's Note The Food and Drug Administration (FDA) on January 28 identified the recall by Empowered Diagnostics (Pompano Beach, Florida) of its CovClear COVID-19 Rapid Antigen Test and ImmunoPass COVID-19 Neutralizing Antibody Rapid Test as Class I, the most serious. Empowered Diagnostics distributed these tests with labeling indicating they were…

Read More

By: Judy Mathias
February 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat